---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-028912"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2026-06-16T21:03:13+00:00"
generated_at: "2026-06-16T21:04:50.077715+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vivos Therapeutics announces proposed rights offering with exercise price floor of $1.25 per share

## Summary
- Each right entitles holder to buy one share at greater of $1.25/share or 20% above market on day before record date.
- Rights are transferable and intended to be listed on an exchange; 9-month exercise period.
- Upon exercise, holder receives a subsequent 9-month right at greater of $1.75/share or 40% above market.
- Record date set as 30th day after SEC declares registration statement effective; no assurance of completion.
- Conditions include SEC effectiveness, shareholder vote for share increase if needed, and board approval.

## SEC filing metadata
- accession: 0001493152-26-028912
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2026-06-16T21:03:13+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000149315226028912/0001493152-26-028912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000149315226028912/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-028912
- JSON: https://secwatch.observer/filing/0001493152-26-028912.json
- Plain text: https://secwatch.observer/filing/0001493152-26-028912.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.